Rewriting RNA by editing exons – How it works
Ascidian Therapeutics represents a new generation of RNA therapeutics company.
Treating disease by replacing entire mutated exons at the RNA level has never before been possible. Today, Ascidian technology excises disease-causing exons and replaces them with wild-type exons to restore normal protein production – in a single reaction, with a single construct. See how:
Ascidian Therapeutics RNA exon editing technology.
